With individuals around the globe concentrated on finding out about Biomarkers, Cancer Therapy and Clinical Research this is your best chance to achieve the biggest gathering of members from the Biomarkers and Clinical Research people group. The organizations involved are Affymetrix, Agilent Technologies, Biomax Informatics, Illumina, Qiagen etc amongst others across the globe.Ĭonference Series LLC Ltd organizes 3000+ Global events in conference series every year across the globe with support from 1000+ more scientific societies and Publishes 700 Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members.

The global market for biomarkers in data statistics is estimated at about $2.4 billion in 2011 and further projected to reach $7.6 billion by 2017 registering a CAGR of 18.3% during the period 2007-2017. It further involves patient segmentation and stratification by successful integration of diagnostic tools and clinical data annotation inclusive of classification distribution metrics and pattern recognition.

Study design and statistical analysis for biomarker research incorporates various tools from bioinformatics.

In addition, biomarkers can be widely used as a tool for disease diagnosis, personalized medication in clinical research.

The past six conference series of biomarkers meeting have grounded the best possible researchers in the field of biomarkers from diverse scientific disciplines, and so will be the upcoming.īiomarkers are important for streamlining drug discovery and development. C onference Series LLC Ltd cordially invites all the participants across the globe to attend the “18th World Congress on Biomarkers, Cancer Therapy & Clinical Research” during September 23-24, 2023 at Vancouver, Canada.īiomarker 2023 congress will enable to put forth the holistic scientific approach to validate the existing and development of novel biomarkers as to better understanding of diseases and diagnosis.

Vancouver medical conferences 2016